CIK 0001641631
- Non-accelerated filer
- Smaller reporting company
Beyond Air, Inc.
Sign in to watch- Ticker
- XAIR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473812456
- Phone
- +1 516-665-8200
- Business address
- 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530
- Former names
- AIT Therapeutics, Inc., KokiCare, Inc.
- Open-market buys, last 90 days
- $62,352
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$62,352. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-04 | Carey Robert Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-03-04 | BENTSUR RON Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-03-04 | BECK DOUGLAS Chief Financial Officer | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-03-04 | Avniel Amir COO and President | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-03-04 | Carey Robert Director | Purchase | +17,000 | $5.70 | $97K | 131,418 |
| 2021-02-18 | Carey Robert Director | Purchase | +15,000 | $6.67 | $100K | 114,418 |
| 2021-02-16 | Lucera Erick Director | Option exercise | +1,171 | $4.25 | $5K | 2,342 |
| 2021-02-16 | Lucera Erick Director | Option exercise · Tranche B Warrant (Right to Buy) | −1,171 | 0 | ||
| 2021-02-14 | Avniel Amir COO and President | Option exercise | +2,342 | $4.25 | $10K | 353,527 |
| 2021-02-14 | Avniel Amir COO and President | Option exercise · Tranche B Warrant (Right to Buy) | −2,342 | 0 | ||
| 2021-02-12 | BENTSUR RON Director | Option exercise | +23,419 | $4.25 | $100K | 205,855 |
| 2021-02-12 | BENTSUR RON Director | Sale | −23,419 | $6.36 | $149K | 182,436 |
| 2021-02-12 | BENTSUR RON Director | Option exercise · Tranche B Warrant (Right to Buy) | −23,419 | 0 | ||
| 2021-02-11 | BENTSUR RON Director | Sale | −1,500 | $6.28 | $9K | 182,436 |
| 2021-02-10 | Lisi Steven A. CEO and Chairman of the Board | Option exercise | +117,112 | $4.25 | $498K | 1,051,875 |
| 2021-02-10 | Lisi Steven A. CEO and Chairman of the Board | Shares withheld for taxes | −70,388 | $7.07 | $498K | 981,487 |
| 2021-02-10 | Lisi Steven A. CEO and Chairman of the Board | Option exercise · Tranche B Warrant (right to buy) | −117,112 | 0 | ||
| 2021-02-10 | Lisi Steven A. CEO and Chairman of the Board | Option exercise | +117,112 | $4.25 | $498K | 1,051,875 |
| 2021-02-10 | Lisi Steven A. CEO and Chairman of the Board | Sale | −70,388 | $7.07 | $498K | 981,487 |
| 2021-02-10 | Lisi Steven A. CEO and Chairman of the Board | Option exercise · Tranche B Warrant (right to buy) | −117,112 | 0 |
Page 19 of 24 · 471 trades